Lenalidomide vs bortezomib maintenance choice post-autologous hematopoietic cell transplantation for multiple myeloma-Reference-Cited by-同舟云学术

Lenalidomide vs bortezomib maintenance choice post-autologous hematopoietic cell transplantation for multiple myeloma

Published:2018-04-27 Issue:6 Volume:53 Page:701-707
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Huang Jennifer,Phillips Sharon,Byrne Michael,Chinratanalab Wichai,Engelhardt Brian G.,Goodman Stacey A.,Harrell Shelton L.,Jagasia Madan,Kassim Adetola,Rawling Kyle T.,Savani Bipin N.,Sengsayadeth Salyka,Cornell R. Frank

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/s41409-018-0177-6.pdf

Reference39 articles.

1. Palumbo A, Cavallo F, Gay F, Di Raimondo F, Ben Yehuda D, Petrucci MT, et al. Autologous transplantation and maintenance therapy in multiple myeloma. N Engl J Med. 2014;371:895–905.

2. Child JA, Morgan GJ, Davies FE, Owen RG, Bell SE, Hawkins K, et al. High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma. N Engl J Med. 2003;348:1875–83.

3. Attal M, Lauwers-Cances V, Hulin C, Leleu X, Caillot D, Escoffre M, et al. Lenalidomide, bortezomib, and dexamethasone with transplantation for myeloma. N Engl J Med. 2017;376:1311–20.

4. Jacobs RW, Saliba RM, Sasaki K, Farhan S, Armas A, Shah ND, et al. Outcome of patients with nonsecretory multiple myeloma after autologous hematopoietic stem cell transplantation. Clin Lymphoma Myeloma Leuk. 2016;16:36–42.

5. Djulbegovic B, Kumar A. Multiple myeloma: detecting the effects of new treatments. Lancet. 2008;371:1642–4.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of Patients with Newly-Diagnosed Multiple Myeloma;Recent Updates on Multiple Myeloma;2023-03-15

2. Real world outcomes of lenalidomide or bortezomib maintenance in patients with multiple myeloma not undergoing stem cell transplantation;Annals of Hematology;2023-03-08

3. Consolidation and maintenance therapy with bortezomib for Vietnamese patients with multiple myeloma after autologous transplantation;Leukemia Research Reports;2023

4. Mechanism of exosomal miR-155 derived from bone marrow mesenchymal stem cells on stemness maintenance and drug resistance in myeloma cells;Journal of Orthopaedic Surgery and Research;2021-10-24

5. Maintenance therapy after second autologous hematopoietic cell transplantation for multiple myeloma. A CIBMTR analysis;Bone Marrow Transplantation;2021-10-04